Biblio Discovery — Demo Discovery Service

197 hasil

Menampilkan 1–20 · 0,45 detik · RSS

Jurnal

Rheumatology & Autoimmunity

Scopus

ISSN 2767-1429 · Wiley · 197 artikel di indeks

  1. Artikel Jurnal

    Farnesoid X receptor prevents hyperuricemia via activating ATP‐binding cassette subfamily G member 2

    Rui Li; Guo Tang; Ye Yu dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract Background The farnesoid X receptor (FXR) is a nuclear receptor that regulates bile acid, lipid, and glucose metabolism. Its role in uric acid (UA) homeostasis, however, remains unclear. This study investigated the potential involvement of FXR in hyperuricemia and explored the underlying…

  2. Artikel Jurnal

    Role of defensins in immunothrombosis

    Yuebing Wang; Guijuan Guo; Xiangjun Liu dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract The interaction between innate immunity and coagulation is essential in thrombotic diseases, but the molecular links remain unclear. Neutrophils are key players, releasing mediators such as defensins, which are small cationic peptides with antimicrobial functions. Defensins contribute to…

  3. Artikel Jurnal

    Infection risk in rheumatoid arthritis patients treated with biologic and targeted therapies

    Lujing Wang; Jieshi Lin; Jie Qian

    Rheumatology & Autoimmunity, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract Biologic therapies have greatly improved the outcome of chronic inflammatory conditions such as rheumatoid arthritis (RA). Patients with RA are at an increased risk of infections, which may be attributed to either the pathological mechanisms of RA itself or treatment‐related…

  4. Artikel Jurnal

    Granzyme K: A new frontier in systemic lupus erythematosus

    Zhongyu Chen; Yunjing Pu; Peihui Yang dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract Systemic lupus erythematosus (SLE) is a complex autoimmune disorder driven by dysregulated adaptive and innate immunity and aberrant complement activity. Although complement activation facilitates immune‐complex clearance, excessive activation aggravates tissue injury. Granzyme K (GZMK), a…

  5. Artikel Jurnal

    Age‐related clinical heterogeneity and peripheral T cell profile alterations in primary Sjögren's disease: A retrospective study of 5778 patients

    Yuan Ning; Ruiling Feng; Kai Zhang dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract Background Numerous studies have explored age‐related heterogeneity in primary Sjögren's disease (SjD); however, the links between clinical phenotypes and underlying immunophenotypes across age groups remain insufficiently defined. Because primary SjD onset is typically gradual and…

  6. Artikel Jurnal

    Type I interferon overactivation in sera of patients with anti‐MDA5‐positive dermatomyositis‐associated interstitial lung disease

    Shohei Nakamura; Yasuhiro Katsumata; Yuko Okamoto dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract Background Rapidly progressive interstitial lung disease (ILD) is a major complication in patients with anti‐melanoma differentiation‐associated gene 5 (MDA5)‐positive dermatomyositis (DM) and carries a poor prognosis despite aggressive immunosuppressive therapy. Emerging evidence suggests…

  7. Artikel Jurnal

    Mesenchymal stromal cell therapy for rheumatoid arthritis: Long‐term efficacy, safety, and mechanistic insights

    Yingjia Chen; Ruiyu Gao; Xing Guo dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 2 · 2026 · Inggris · DOAJ Scopus

    Abstract Rheumatoid arthritis (RA) is a multifactorial autoimmune disease primarily characterized by erosive arthritis. It can lead to joint pain, swelling, and deformity, significantly affecting patients' quality of life. RA results from the interaction of multiple factors, including genetic…

  8. Artikel Jurnal

    Impact of fibromyalgia on patient acceptable symptom state in Thai patients with spondyloarthritis: A cross‐sectional study

    Sittikorn Srivorrapattarakul; Praveena Chiowchanwisawakit

    Rheumatology & Autoimmunity, Vol. 6 No. 2 · 2026 · Inggris · DOAJ Scopus

    Abstract Background The interplay between inflammatory disease activity and centralized pain processing represents a significant challenge in the clinical management of spondyloarthritis. In patients with spondyloarthritis, the co‐occurrence of fibromyalgia may significantly influence patients'…

  9. Artikel Jurnal

    Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis

    Masafumi Sugiyama; Saki Okuda‐Tsuchimoto; Takashi Tsuchimoto dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 2 · 2026 · Inggris · DOAJ Scopus

    Abstract Background In patients with rheumatoid arthritis (RA), patient‐reported outcomes (PROs) may vary by disease‐modifying antirheumatic drug (DMARD) class. This study aimed to assess the impact of biological/targeted synthetic DMARDs (b/tsDMARDs) on PROs in patients with sustained low RA…

  10. Artikel Jurnal

    The evolving role of regulatory T cells in Sjögren's disease pathogenesis and the promise of Treg‐based therapies: A comprehensive review

    Gagan Urs; Bharath Raj Srinivasan; Himabindu Jayaprakash Narayan dkk.

    Rheumatology & Autoimmunity, Vol. 6 No. 2 · 2026 · Inggris · DOAJ Scopus

    Abstract Sjögren's disease (SjD) is a chronic systemic autoimmune disorder characterised by exocrine gland dysfunction and diverse systemic manifestations. While both innate and adaptive immune dysregulation contribute to pathogenesis, growing evidence highlights a central role for regulatory T…

  11. Artikel Jurnal

    Clinical significance of antinuclear antibodies in patients with Kikuchi‐Fujimoto disease: A retrospective cohort study

    Xia Zhang; Rui Yan; Yanying Liu

    Rheumatology & Autoimmunity, Vol. 6 No. 2 · 2026 · Inggris · DOAJ Scopus

    Abstract Background The clinical significance of antinuclear antibodies (ANA) in Kikuchi‐Fujimoto disease (KFD) remains unclear, particularly whether ANA positivity predicts progression to autoimmune diseases. This study aimed to investigate the association of ANA with clinical features and…

  12. Artikel Jurnal

    Long‐term remission in gout: Challenges and future opportunities

    Patapong Towiwat; Zhanguo Li

    Rheumatology & Autoimmunity, Vol. 6 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Among rheumatic diseases, the prevalence of gout is increasing with population growth and aging. While hyperuricemia remains the major risk factor, gout is now recognized as a curable disease. Several recommendations have been proposed to achieve treatment goals; however, only a small…